Ruscito, Ilary
Cacsire Castillo-Tong, Dan
Vergote, Ignace
Ignat, Iulia
Stanske, Mandy
Vanderstichele, Adriaan
Glajzer, Jacek
Kulbe, Hagen
Trillsch, Fabian
Mustea, Alexander
Kreuzinger, Caroline
Benedetti Panici, Pierluigi
Gourley, Charlie
Gabra, Hani
Nuti, Marianna
Taube, Eliane T.
Kessler, Mirjana
Sehouli, Jalid
Darb-Esfahani, Silvia
Braicu, Elena Ioana
Article History
Received: 18 February 2018
Revised: 22 May 2018
Accepted: 1 June 2018
First Online: 29 June 2018
Competing interests
: The authors declare that they have no conflict of interest.
: Data supporting the results reported are stored in the OCTIPS Consortium database. The documentation of clinical and patient’s data was managed with “AlcedisTRIAL the web based documentation system” of Alcedis GmbH, Winchesterstr. 3, 35394 Giessen, Germany.
: Included patients had previously signed written informed consent regarding the anonymous publication of their clinico-pathological data for translational research purposes.
: European Community’s Seventh Framework Program supported this study under the grant agreement No. 279113-2 (OCTIPS). BMBF supported this study under the Transcan project TH4Respons, grant No.: JTC 2014-121.
: Included patients were previously treated in one of the European Gynaecologic Oncology referral Centers of the following Institutions: Charité Universitätsmedizin Berlin, Germany; Catholic University of Leuven, Belgium; Imperial College, London, UK; University of Edinburgh, UK; University Medical Center Hamburg-Eppendorf, Germany. Patients had previously signed written informed consent regarding tumour tissue sampling and the collection of their clinico-pathological data for translational research purposes. Approval from each local ethics committee was obtained (EK207/2003, ML2524, 05/Q0406/178, EK130113, 06/S1101/16). The study was performed in accordance with the Declaration of Helsinki.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).